| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |